Dr. Sylvie Trottier is the director of the Department of Microbiology-Infectology and Immunology at the Université Laval as well as a researcher at the Centre Hospitalier de l’Université Laval.

Dr. Trottier is a co-investigator for five CTN studies. Three of them are in the Clinical Management Sciences core: CTN 293: REPRIEVE Trial, CTN 240: VALIDATE Trial, and CTN 254: Inflammation as a predictor of HIV disease progression. The other two are CTN 247: Canadian cohort of HIV+ slow progressors, in the Vaccines and Immunotherapies core, and CTN 286: TriiAdd Study, in the Co-infections and Concurrent Diseases core.